<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044974</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Author´s reply to "çOn the new guidelines for inhibitors of hemostasis and regional neuraxial anesthesia"</dc:title>
<dc:creator>Llau Pitarch, J. V</dc:creator>
<dc:creator>Andrés Ibáñez, J. de</dc:creator>
<dc:creator>Gomar Sancho, C</dc:creator>
<dc:creator>Gómez Luque, A</dc:creator>
<dc:creator>Torres Morera, L. M</dc:creator>
<dc:creator>Hidalgo Martínez, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;53(3): 200-201, mar. 2006.</dc:source>
<dc:identifier>ibc-044974</dc:identifier>
<dc:title xml:lang="es">Respuesta a la carta al director &#147;consideraciones sobre la nueva guía de fármacos inhibidores de la hemostasia y anestesia regional neuroaxial&#148;</dc:title>
<dc:subject>^d932^s22020</dc:subject>
<dc:subject>^d6484^s22012</dc:subject>
<dc:subject>^d14308^s22054</dc:subject>
<dc:subject>^d932^s22073</dc:subject>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d11799^s22048</dc:subject>
<dc:subject>^d32645^s22054</dc:subject>
<dc:subject>^d778</dc:subject>
<dc:subject>^d6556^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1807</dc:subject>
<dc:subject>^d11729^s22020</dc:subject>
<dc:subject>^d932^s22000</dc:subject>
<dc:subject>^d11622^s22054</dc:subject>
<dc:subject>^d7593^s22054</dc:subject>
<dc:subject>^d28075^s22000</dc:subject>
<dc:subject>^d24646^s22006</dc:subject>
<dc:subject>^d33561</dc:subject>
<dc:subject>^d11383</dc:subject>
<dc:type>article</dc:type>
<dc:date>200603</dc:date>
</metadata>
</record>
</ibecs-document>
